Quality of Life Study for Sickle Cell Patients Treated With Jobelyn (Sorghum Bicolor Extract)

NCT01704794 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Other Sickle-cell Disorders With Crisis, Unspecified

Interventions

DIETARY_SUPPLEMENT: Folic Acid + Paludrine + Jobelyn (500mg)
DRUG: Folic Acid + Paludrine + Jobelyn (250mg)
DIETARY_SUPPLEMENT: Folic Acid + Paludrine + Jobelyn (2mg)

Sponsor

Lagos State University